Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Post-Market Plan Gains Support, But Many Details Still Lacking

17 Sep 2012

Related Content

FDA’s UDI Draft Rule Details Device Marking, Database Submission Mandates

09 Jul 2012

Leveraging Registries: A Next Step In National Post-Market Plan

17 Sep 2012

FDA MDEpiNet Panel: Device Surveillance Balancing Act

17 Sep 2012

FDA Unveils Plan To Strengthen Device Post-Market Surveillance

10 Sep 2012

Midwest Hospitals Prepare For Stent Unique-Device-Identifier Demo

16 Apr 2012

With eMDRs On The Way, Many Firms Are Updating Complaint Handling Systems

25 Jul 2011

Additional Topics

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.